Fertility: Infection and Inflammation
Launched by MEDICAL UNIVERSITY OF GRAZ · Feb 13, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Fertility: Infection and Inflammation," aims to better understand how infections and inflammation may affect fertility in women undergoing in vitro fertilization (IVF). Researchers are looking at various factors in blood samples and other collected materials to see if they can predict whether a pregnancy will be successful. They will analyze things like hormones, immune markers, and signs of viral infections, which could all play a role in fertility problems. By studying these factors, the investigators hope to uncover new insights that could help improve pregnancy outcomes for couples facing fertility challenges.
To participate in this study, women aged 18 and older, along with their partners, can join if they give consent. Those who are minors or unable to provide consent will not be included. Participants can expect to provide several samples, including blood and other bodily fluids, during different stages of the IVF process. The study will track various outcomes, such as the success of the IVF procedure, the health of the newborn, and other important fertility-related information. This trial is currently recruiting participants and is focused on understanding how specific health factors influence fertility and pregnancy.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women, and optionally their partners, aged 18 or older with written consent to participate in the study.
- Exclusion Criteria:
- • Minors and patients unable to provide consent. Conditions or circumstances that, in the opinion of the investigator or treating physician, could interfere with the study.
About Medical University Of Graz
The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Graz, , Austria
Graz, , Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported